Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

InfectoPharm

Status: Completed

Conditions: Bacterial Infection

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01173575

J&P009SAN/2009

Details and patient eligibility

About

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.

Primary objective:

• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.

Secondary objectives:

• To determine the rate and severity of unexpected adverse events.
• To determine the mean duration of therapy with FOM in patients with bacterial infection.

Study design:

Multi-center, non-interventional study

Full description

Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J&P MEDICAL RESEARCH LTD.

Enrollment: 209 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.

Exclusion criteria

Trial design

209 participants in 1 patient group

Bacterial Infection

Description:

All Patients with bacterial infection receiving fosfomycin may be included